Medigen Vaccine Biologics Financial Flexibility Index
Medigen Vaccine Biologics financial flexibility index. Medigen Vaccine Biologics (6547) has a Financial Flexibility Index of -0.05x as of June 2026. Free cash flow of NT$-58.48 Million (operating CF NT$-91.20 Million minus capex NT$32.72 Million) represents 0% of total liabilities (NT$1.21 Billion). See Medigen Vaccine Biologics (6547) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Medigen Vaccine Biologics (2012–2025)
Financial flexibility index of Medigen Vaccine Biologics from 2012 to 2025. Historical Financial Flexibility Index trend for Medigen Vaccine Biologics across 14 annual periods. Check 6547 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Medigen Vaccine Biologics Financial Flexibility Index by Year (2012–2025)
Medigen Vaccine Biologics financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Medigen Vaccine Biologics. For the full cash flow conversion analysis, see cash flow conversion of Medigen Vaccine Biologics.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | NT$2.69 Million | NT$-49.09 Million | NT$454.64 Million | ▼ -96.0% |
| 2024 | 0.15x | NT$75.73 Million | NT$40.75 Million | NT$513.92 Million | ▲ +175.8% |
| 2023 | -0.19x | NT$-436.80 Million | NT$-477.75 Million | NT$2.25 Billion | ▲ +53.1% |
| 2022 | -0.41x | NT$-960.62 Million | NT$-1.10 Billion | NT$2.32 Billion | ▼ -136.1% |
| 2021 | 1.15x | NT$714.85 Million | NT$579.89 Million | NT$622.95 Million | ▲ +182.7% |
| 2020 | -1.39x | NT$-484.67 Million | NT$-589.97 Million | NT$349.40 Million | ▼ -265.7% |
| 2019 | -0.38x | NT$-345.27 Million | NT$-462.65 Million | NT$910.28 Million | ▲ +32.4% |
| 2018 | -0.56x | NT$-320.44 Million | NT$-356.33 Million | NT$571.10 Million | ▼ -169.6% |
| 2017 | -0.21x | NT$-128.06 Million | NT$-217.03 Million | NT$615.41 Million | ▼ -124.0% |
| 2016 | 0.87x | NT$301.05 Million | NT$-163.37 Million | NT$347.90 Million | ▼ -60.3% |
| 2015 | 2.18x | NT$673.41 Million | NT$216.26 Million | NT$309.19 Million | ▲ +473.1% |
| 2014 | -0.58x | NT$-79.37 Million | NT$-513.98 Million | NT$135.95 Million | ▲ +69.3% |
| 2013 | -1.90x | NT$-37.01 Million | NT$-72.36 Million | NT$19.46 Million | ▼ -142.4% |
| 2012 | 4.48x | NT$99.29 Million | NT$-5.47 Million | NT$22.15 Million | — |